HIGHLIGHTS
- who: Toluwase Fatoki from the Federal University Oye-Ekiti, PMB, Oye-Ekiti, Ekiti State, Nigeria have published the paper: Harmine and 7,8-dihydroxyflavone synergistically suitable for amyotrophic lateral sclerosis management: An, in the Journal: (JOURNAL)
- what: The aim of this work was to predict the pharmacokinetics and identify unique protein targets that are associated with potential anti-ALS phytochemicals and FDA-approved drugs, by in silico approaches. This study shows that riluzole and harmine have closely similar physicochemical and pharmacokinetics properties as well as molecular targets, such as norepinephrine transporter (SLC6A2). This study shows . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.